8 Results for "

IKCa channel

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "IKCa channel" in MCE Product Catalog:

30
30 Cited Publications
Cat. No.: HY-13519
CAS No.: 289905-88-0
Purity:  99.73%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

TRAM-34 is a highly selective blocker of intermediate-conductance calcium-activated K + channel (IKCa1) (Kd=20 nM).
loading...
    loading...
Cat. No.: HY-102052
CAS No.: 60563-36-2
Purity:  99.25%
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

DCEBIO is a small/medium conductance calcium-activated potassium (SKCa/IKCa) channel opener and primary neuron signal blocker. It hyperpolarizes the membrane potential of C2C12 myoblasts by activating IKCa channels, thereby promoting myogenic differentiation. The specific biological activity of DCEBIO is manifested in increased myotube formation, enhanced myosin heavy chain II protein levels and myogenin mRNA levels. DCEBIO can be applied in the field of muscle research, especially in muscle-related degenerative diseases such as sarcopenia .
loading...
    loading...
Cat. No.: HY-108592
CAS No.: 918311-87-2
Purity:  98.91%
UCL 2077 is a potassium channel and slow afterhyperpolarization (sAHP) inhibitor. UCL 2077 selectively blocks sAHP channels without affecting L-type Ca 2+ currents. UCL 2077 blocks KCNQ1- and KCNQ2-containing K + channels, decreases erg current amplitude, increases erg deactivation rate. UCL 2077 can be used for the research of hippocampus-dependent memory retrieval deficit and cardiac arrhythmias .
loading...
    loading...
Cat. No.: HY-103308
CAS No.: 197525-99-8
Purity:  99.66%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-130070
CAS No.: 1259536-70-3
Purity:  98.77%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

QO-40, a pyrazolo[1,5-a]pyrimidine-7(4H)-one (PPO) derivative, is a KCNQ2/KCNQ3 K + channels activator with an EC50 of 6.94 μM. QO-40 stimulated Ca 2+-activated K + current (IK(Ca)) with an EC50 value of 2.3 μM in pituitary GH3 lactotrophs .
loading...
    loading...
Cat. No.: HY-187127
CAS No.: 427-24-7
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

(2-Fluorophenyl) diphenylmethanol is a IKCa1 channel blocker with a Kd value of 700 nM. (2-Fluorophenyl) diphenylmethanol is used in the research of graft-versus-host disease and inflammatory diseases .
loading...
    loading...
Cat. No.: HY-102052R
CAS No.: 60563-36-2
Research Areas:  

Metabolic Disease

DCEBIO (Standard) is the analytical standard of DCEBIO (HY-102052). This product is intended for research and analytical applications. DCEBIO is a small/medium conductance calcium-activated potassium (SKCa/IKCa) channel opener and primary neuron signal blocker. It hyperpolarizes the membrane potential of C2C12 myoblasts by activating IKCa channels, thereby promoting myogenic differentiation. The specific biological activity of DCEBIO is manifested in increased myotube formation, enhanced myosin heavy chain II protein levels and myogenin mRNA levels. DCEBIO can be applied in the field of muscle research, especially in muscle-related degenerative diseases such as sarcopenia .
loading...
    loading...
Cat. No.: HY-103308R
CAS No.: 197525-99-8
TRAM-39 (Standard) is the analytical standard of TRAM-39 (HY-103308). This product is intended for research and analytical applications. TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease .
loading...
    loading...